Richard Lehman reviews the latest research in the top medical journals […]
Richard Lehman’s weekly review of medical journals
Richard Lehman’s journal review—8 May 2017
Richard Lehman reviews the latest research in the top medical journals […]
Richard Lehman’s journal review—2 May 2017
Richard Lehman reviews the latest research in the top medical journals […]
Richard Lehman’s journal review—24 April 2017
Richard Lehman reviews the latest research in the top medical journals […]
Richard Lehman’s journal review—17 April 2017
Richard Lehman reviews the latest research in the top medical journals […]
Richard Lehman’s journal review—10 April 2017
“Shared understanding is the central challenge of medicine in this century.” Read this week’s research reviews by Richard Lehman. […]
Richard Lehman’s journal review—3 April 2017
NEJM 30 Mar 2017 Vol 376 Rivaroxaban vs aspirin long after VTE The longer you give anticoagulants to people following venous thromboembolism, the fewer subsequent thromboembolic events they will have. […]
Richard Lehman’s journal review—27 March 2017
Richard Lehman reviews the latest research in the leading medical journals […]
Richard Lehman’s journal review—20 March 2017
NEJM 16 Mar 2017 Vol 376 Stem cells for AMD For sufferers of age-related macular degeneration who were hoping for a stem cell cure, this week’s New England Journal brings […]
Richard Lehman’s journal review—13 March 2017
NEJM 9 Mar 2017 Vol 376 Impressive imatinib In my childhood, somebody behaving self-importantly was referred to as “his nibs.” Today, the nibs of medicine are very proud of themselves. […]